• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,009.70 -479.26
( -0.63%)
Global Indices
Nasdaq
50,600.70 294.03
(0.58%)
Dow Jones
7,494.47 27.75
(0.37%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
95.61 -0.67
(-0.70%)
EUR-INR
110.97 -0.85
(-0.76%)
GBP-INR
128.43 -0.86
(-0.66%)
JPY-INR
0.60 0.00
(-0.79%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
317.33
72.59
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

Acuité Ratings upgrades ratings of Permanent Magnets to 'BBB/A3+'
Feb 25,2026

The agency has also upgraded the company’s short-term rating to 'ACUITE A3+’ from ‘ACUITE A3’.

Acuité Ratings & Research stated that the rating upgrade factors in the group’s stable business risk profile which is expected to strengthen further with augmentation in capacity utilisations and addition of new capacities facilitating diversification in product mix.

The rating also factors in group’s sustained healthy financial risk profile, supported by a strong net worth base, low gearing and comfortable debt protection metrics. The rating also reflects the group’s long standing operational track record and experienced management.

However, the rating remains constrained by the group’s working capital-intensive operations and susceptibility of profitability to volatility in raw material prices in a highly competitive and fragmented industry.

Permanent Magnets (PML) is engaged in manufacturing of Alnico (aluminium, nickel and cobalt) magnets & magnetic assemblies, parts and accessories of electricity meters, gas meters and electrical vehicles.

The scrip rose 0.54% to currently trade at Rs 840.55 on the BSE.